Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Paul A Vanderlaan, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Paul Vanderlaan and Vanda Torous.
Connection Strength

2.546
  1. Comparison of plasma-thrombin, HistoGel, and CellGel cell block preparation methods with paired ThinPrep slides in the setting of mediastinal granulomatous disease. J Am Soc Cytopathol. 2019 Mar - Apr; 8(2):52-60.
    View in: PubMed
    Score: 0.799
  2. PD-L1 testing using the clone 22C3 pharmDx kit for selection of patients with non-small cell lung cancer to receive immune checkpoint inhibitor therapy: are cytology cell blocks a viable option? J Am Soc Cytopathol. 2018 May-Jun; 7(3):133-141.
    View in: PubMed
    Score: 0.768
  3. Implementation of the Paris System for Reporting Urinary Cytology results in lower atypical diagnostic rates. J Am Soc Cytopathol. 2017 Sep - Oct; 6(5):205-210.
    View in: PubMed
    Score: 0.731
  4. A frameshift error affecting multiple cytology cell blocks: Lessons from a near-miss event. Cancer Cytopathol. 2021 Oct 28.
    View in: PubMed
    Score: 0.248
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.